Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

The report highlights that insulin-derived amyloidosis can mimic other injection-site reactions and should be considered when ...

Doctors break down the difference between Wegovy’s GLP-1 injections and pills, plus how to decide which is right for you.

Many jails and prisons around the country don't provide medication treatment for opioid use disorder. Studies show that ...

Results of the SPACE trial demonstrating the safety and efficacy of subcutaneous fremanezumab for the prevention of pediatric ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of ...

Enable Injections, Inc. (“Enable”) a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients with severe unmet needs, today announced that its Phase Ib/II study of ...

The Inducement Grant has a ten-year term and an exercise price per share of $19.93, which is equal to the closing price of Zenas’ common stock on the Grant Date. The Inducement Grant will vest over a ...